By Professor Nada Hamad

Journal articles

Hewitt J; Hamad N; Beecher C; Turner T; Chakraborty S, 2024, 'Poor reporting limited consideration of EDI in the Australian guidelines for the clinical care of people with COVID-19', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111361

Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemuary M; Elsawy M; Guilcher GM; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R, 2024, 'International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update', Transplantation and Cellular Therapy, 30, pp. 349 - 385, http://dx.doi.org/10.1016/j.jtct.2023.12.001

Fotheringham P; Safi N; Li Z; Anazodo A; Remond M; Hayen A; Currow D; Roder D; Hamad N; Nicholl M; Gordon A; Frawley J; Sullivan EA, 2024, 'Pregnancy-associated gynecological cancer in New South Wales, Australia 1994–2013: A population-based historical cohort study', Acta Obstetricia et Gynecologica Scandinavica, 103, pp. 729 - 739, http://dx.doi.org/10.1111/aogs.14530

Binkley MS; Flerlage JE; Savage KJ; Akhtar S; Steiner R; Zhang X-Y; Dickinson M; Prica A; Major A; Hendrickson PG; Hopkins D; Ng A; Casulo C; Baron J; Roberts KB; Al Kendi J; Balogh A; Ricardi U; Torka P; Specht L; De Silva R; Pickard K; Blazin LJ; Henry M; Smith CM; Halperin D; Brady J; Brennan B; Senchenko MA; Reeves M; Hoppe BS; Terezakis S; Talaulikar D; Picardi M; Kirova Y; Fergusson P; Hawkes EA; Lee D; Doo NW; Barraclough A; Cheah CY; Ku M; Hamad N; Mutsando H; Gilbertson M; Marconi T; Viiala N; Maurer MJ; Eichenauer DA; Hoppe RT; GLOW Consortium , 2024, 'International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.', J Clin Oncol, pp. JCO2301655, http://dx.doi.org/10.1200/JCO.23.01655

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson AM; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2024, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies', Transplantation and Cellular Therapy, 30, pp. 334.e1 - 334.e7, http://dx.doi.org/10.1016/j.jtct.2023.11.018

Minson A; Hamad N; Cheah CY; Tam C; Blombery P; Westerman D; Ritchie D; Morgan H; Holzwart N; Lade S; Anderson MA; Khot A; Seymour JF; Robertson M; Caldwell I; Ryland G; Saghebi J; Sabahi Z; Xie J; Koldej R; Dickinson M, 2024, 'CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study', Blood, 143, pp. 673 - 684, http://dx.doi.org/10.1182/blood.2023021306

Campbell A; Teh B; Mulligan S; Ross DM; Weinkove R; Gilroy N; Gangatharan S; Prince HM; Szer J; Trotman J; Lane S; Dickinson M; Quach H; Enjeti AK; Ku M; Gregory G; Hapgood G; Ho PJ; Cochrane T; Cheah C; Greenwood M; Latimer M; Berkahn L; Wight J; Armytage T; Diamond P; Tam CS; Hamad N, 2024, 'Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies', Internal Medicine Journal, 54, pp. 328 - 336, http://dx.doi.org/10.1111/imj.16303

Peacock A; Dehle F; Mesa Zapata O; Gennari F; Williams M; Hamad N; Larsen S; Harrison S; Taylor C, 2024, 'Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease', Journal of Health Economics and Outcomes Research, pp. 23 - 31, http://dx.doi.org/10.36469/jheor.2024.92028

Minson A; Hamad N; Di Ciaccio P; Talaulikar D; Ku M; Ratnasingam S; Cheah C; Yannakou CK; Bishton M; Ng ZY; Agrawal S; McQuillan A; Johnston A; Choong E; Wong K; McQuillan J; Beekman A; Hawkes E; Dickinson M, 2024, 'Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom', British Journal of Haematology, 204, pp. 548 - 554, http://dx.doi.org/10.1111/bjh.19179

Blennerhassett R; Hamad N; Grech L; Kwok A; Choi T; Forsyth C; Jagger J; Opat S; Harris S; Chan BA; Nguyen M; Bain N; Day D; Segelov E; CANVACCS investigators , 2024, 'Attitudes towards COVID-19 vaccination in adults with haematological malignancies.', Acta Haematol, http://dx.doi.org/10.1159/000536548

Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N, 2024, 'The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma', Blood, 143, pp. 152 - 165, http://dx.doi.org/10.1182/blood.2023021348

Peacock A; Dehle FC; Mesa Zapata OA; Gennari F; Williams MRI; Hamad N; Larsen S; Harrison SJ; Taylor C, 2024, 'Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease', Journal of Health Economics and Outcomes Research, 11, pp. 23 - 31, http://dx.doi.org/10.36469/001c.92028

Kröger N; Bacigalupo A; Barbui T; Ditschkowski M; Gagelmann N; Griesshammer M; Gupta V; Hamad N; Harrison C; Hernandez-Boluda JC; Koschmieder S; Jain T; Mascarenhas J; Mesa R; Popat UR; Passamonti F; Polverelli N; Rambaldi A; Robin M; Salit RB; Schroeder T; Scott BL; Tamari R; Tefferi A; Vannucchi AM; McLornan DP; Barosi G, 2024, 'Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group', The Lancet Haematology, 11, pp. e62 - e74, http://dx.doi.org/10.1016/S2352-3026(23)00305-8

Manos K; Churilov L; Grigg A; Di Ciaccio P; Wong J; Chandra Sekaran U; Wight J; Goh Z; Jina H; Butler L; Yannakou CK; Hamad N; Gregory GP; Gangatharan S; Cochrane T; Hawkes EA; Lasica M, 2024, 'Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study', British Journal of Haematology, http://dx.doi.org/10.1111/bjh.19407

Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GMT; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R, 2024, 'International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update', Bone Marrow Transplantation, http://dx.doi.org/10.1038/s41409-023-02190-2

Shaw B; Chung E; Wellard C; Yoo E; Bennett R; Birks C; Johnston A; Cheah CY; Hamad N; Simpson J; Barraclough A; Ku M; Viiala N; Ratnasingam S; Armytage T; Cochrane T; Chong G; Lee D; Manos K; Keane C; Wallwork S; Opat S; Hawkes EA, 2024, 'Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.', EJHaem, 5, pp. 325 - 332, http://dx.doi.org/10.1002/jha2.870

Lewis KL; Jakobsen LH; Villa D; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Bishton MJ; Fox CP; Hawkes EA; Maurer MJ; El-Galaly TC; Cheah CY; International CNS Prophylaxis Study Group , 2023, 'High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.', J Clin Oncol, 41, pp. 5376 - 5387, http://dx.doi.org/10.1200/JCO.23.00365

Hamad N; Bilmon I; Chee L; Henden A; Johnston A; Purtill D; Bajel A; Tey SK; Yeung D; Cole T; Lewis C; Butler J, 2023, 'ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease', Internal Medicine Journal, 53, pp. 2319 - 2329, http://dx.doi.org/10.1111/imj.16255

Gurnari C; Robin M; Godley LA; Drozd-Sokołowska J; Włodarski MW; Raj K; Onida F; Worel N; Ciceri F; Carbacioglu S; Kenyon M; Aljurf M; Bonfim C; Makishima H; Niemeyer C; Fenaux P; Zebisch A; Hamad N; Chalandon Y; Hellström-Lindberg E; Voso MT; Mecucci C; Duarte FB; Sebert M; Sicre de Fontbrune F; Soulier J; Shimamura A; Lindsley RC; Maciejewski JP; Calado RT; Yakoub-Agha I; McLornan DP, 2023, 'Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT', The Lancet Haematology, 10, pp. e994 - e1005, http://dx.doi.org/10.1016/S2352-3026(23)00265-X

Safi N; Li Z; Anazodo A; Remond M; Hayen A; Currow D; Roder D; Hamad N; Nicholl M; Gordon A; Frawley J; Fotheringham P; Sullivan E, 2023, 'Pregnancy associated cancer, timing of birth and clinical decision making—a NSW data linkage study', BMC Pregnancy and Childbirth, 23, http://dx.doi.org/10.1186/s12884-023-05359-1

Tang C; Zhang L; Suleman A; Lewis KL; Quinn D; Poon M; Hann W; Pringle E; Cherepanoff S; Coyle L; Kassam S; McKay P; Cheah CY; Prica A; Smith J; Hamad N, 2023, 'An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators', Blood, 142, pp. 3132 - 3132, http://dx.doi.org/10.1182/blood-2023-178431

Lewis KL; Blombery P; Sungala NP; Ma CKK; Giri P; Vanguru V; Cochrane T; Czerwinski JK; Lee D; Hamad N; Francis R; Walia M; Carlson J; Butcher BE; Cheah CY, 2023, 'Australasian Leukaemia & Lymphoma Group NHL35-Pacific: An Open Label Phase II Study of Pembrolizumab and Chemo-Immunotherapy As First-Line Therapy for Primary Mediastinal B-Cell Lymphoma - Trial in Progress', Blood, 142, pp. 3103 - 3103, http://dx.doi.org/10.1182/blood-2023-185160

Mizuno S; Gras L; Baaij L; Koster L; D'Souza A; Hari PN; Estrada-Merly N; Saber W; Cowan AJ; Iida M; Okamoto S; Takamatsu H; Kawamura K; Kodera Y; Hamad N; Ko B-S; Liam C; HO KIMW; Goh AS; Tan SK; Elhaddad AM; Bazarbachi A; Chaudhry BQUN; Alfar R; Bekadja MA; Benakli M; Frutos Ortiz CA; Riva E; Galeano S; Bass F; Mian H; McCurdy A; Wang FR; Neumann D; Koh MBC; Snowden J; Schönland S; McLornan DP; Hayden PJ; Sureda Balari AM; Greinix HT; Aljurf M; Atsuta Y; Niederwieser DW; Garderet L, 2023, 'Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study', Blood, 142, pp. 785 - 785, http://dx.doi.org/10.1182/blood-2023-179153

Rajasekariah H; McCaughan G; Ma CKK; Gorrie N; Milliken S; Ma D; Fay K; Withers B; Hamad N; Birch S; Keogh A; Jabbour A; Hayward C; Macdonald P; Moore J, 2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319

Zeiser R; Russo D; Ram R; Hashmi SK; Chakraverty R; Middeke JM; Musso M; Giebel S; Uzay A; Langmuir P; Hamad N; Li X; Gowda M; Stefanelli T; Lee SJ; Teshima T; Locatelli F, 2023, 'Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study', Blood, 142, pp. 654 - 654, http://dx.doi.org/10.1182/blood-2023-172590

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907

Pabst T; Papayannidis C; Demirkan F; Doronin V; Fogliatto LM; Guttke C; Gyan E; Hamad N; Herrera P; Hultberg A; Jacobs J; Johnson AJ; Langlois A; Ma X; Martinelli G; Arnan M; Müller R; Nottage K; Ofran Y; Özcan M; Samoilova O; Tolbert JA; Trudel GC; Xiu L; Vey N; Wei AH, 2023, 'Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study', The Lancet Haematology, 10, pp. e902 - e912, http://dx.doi.org/10.1016/S2352-3026(23)00207-7

Blennerhassett R; Othman J; Biscoe A; Kliman D; Mills G; Blyth E; Micklethwaite K; Kwan J; Bilmon I; Bhattacharyya A; Panicker S; Fay K; Milliken S; Ma D; Hamad N; Stevenson W; Arthur C; Moore J; Greenwood M; Gottlieb D; Kerridge I, 2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, 53, pp. 1979 - 1986, http://dx.doi.org/10.1111/imj.16043

Luke JJ; Patel MR; Blumenschein GR; Hamilton E; Chmielowski B; Ulahannan SV; Connolly RM; Santa-Maria CA; Wang J; Bahadur SW; Weickhardt A; Asch AS; Mallesara G; Clingan P; Dlugosz-Danecka M; Tomaszewska-Kiecana M; Pylypenko H; Hamad N; Kindler HL; Sumrow BJ; Kaminker P; Chen FZ; Zhang X; Shah K; Smith DH; De Costa A; Li J; Li H; Sun J; Moore PA, 2023, 'The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial', Nature Medicine, 29, pp. 2814 - 2824, http://dx.doi.org/10.1038/s41591-023-02593-0

Farooq F; Brandt JS; Cardonick E; Polushkina E; Vose J; Ahmed S; Geethakumari PR; Olszewski AJ; Yasin H; Farooq U; Hamad N; Lin Y; Maggen C; Fruscio R; Gziri MM; Steffensen KD; Amant F; Evens AM, 2023, 'An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy', Blood Advances, 7, pp. 5480 - 5484, http://dx.doi.org/10.1182/bloodadvances.2023010090

Moore J; Hamad N; Gottlieb D; Bajel A; Ritchie D; Yeung D; Greenwood M; Purtill D; Tran S; Solterbeck A; Aarons D; Kwan J, 2023, 'Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study', Blood Advances, 7, pp. 5554 - 5565, http://dx.doi.org/10.1182/bloodadvances.2023009840

Barraclough A; England JT; Villa D; Wight J; Hapgood G; Conn J; Doo NW; Li EW; Gilbertson M; Shaw B; Bishton MJ; Saeed M; Ratnasingam S; Abeyakoon C; Chong G; Wai SH; Ku M; Lee HP; Fleming K; Tam C; Douglas G; Cheah CY; Ng ZY; Rolfe T; Mills AK; Hamad N; Cashman H; Gleeson M; Narayana M; Hawkes EA, 2023, 'Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance', Haematologica, 108, pp. 2444 - 2453, http://dx.doi.org/10.3324/haematol.2022.281375

Taher A; Abadir E; McCluskey P; Hamad N; Lo TH; Heydon P, 2023, 'PRESUMPTIVE RECURRENCE OF INTRAOCULAR LYMPHOMA DESPITE CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY', Retinal Cases and Brief Reports, 17, pp. 562 - 566, http://dx.doi.org/10.1097/ICB.0000000000001246

Novitzky-Basso I; Linn SM; White J; Elemary M; Xenocostas A; Deotare U; Kelly K; Hamad N; Tan S; Culos S; Law A; Kumar R; Mattsson J; Kim DDH, 2023, 'Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure', Bone Marrow Transplantation, 58, pp. 1024 - 1032, http://dx.doi.org/10.1038/s41409-023-02020-5

Minson A; Verner E; Giri P; Min Wong S; Ratnasingam S; Butler J; Janowski W; Ku M; Cheah C; Hertzberg M; Herbert K; Hamad N; Yannakou C; Neeson P; Saghebi J; Blombery P; Robertson M; Shong Lau L; Xie J; Seymour J; Dickinson M, 2023, 'P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALYSIS OF THE COALITION STUDY', HemaSphere, 7, pp. e8608732 - e8608732, http://dx.doi.org/10.1097/01.hs9.0000971364.86087.32

Shaw B; Chung E; Wellard C; Yoo E; Bennett R; Birks C; Johnston A; Cheah C; Hamad N; Simpson J; Barraclough A; Ku M; Viiala N; Ratnasingam S; Armytage T; Cochrane T; Chong G; Lee D; Manos K; Keane C; Wallwork S; Opat S; Hawkes EA, 2023, 'P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY', HemaSphere, 7, pp. e24670ab - e24670ab, http://dx.doi.org/10.1097/01.hs9.0000971668.24670.ab

Dickinson M; Hamad N; Bryant C; Kothari N; Ojeras P; Vohra A; Lin M; Tohme M; Trager J; Shook D; Kennedy G; Tees M; Hill BT, 2023, 'S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES', HemaSphere, 7, pp. e37234fb - e37234fb, http://dx.doi.org/10.1097/01.hs9.0000967956.37234.fb

Okamoto S; Iida M; Hamad N; Duarte FB; Sureda A; Srivastava A; Galeano S; Chao N; Rondelli D; Flowers ME, 2023, 'American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting', Transplantation and Cellular Therapy, 29, pp. 410 - 417, http://dx.doi.org/10.1016/j.jtct.2023.02.024

Murthy GSG; Kim S; Estrada-Merly N; Abid MB; Aljurf M; Assal A; Badar T; Badawy SM; Ballen K; Beitinjaneh A; Cerny J; Chhabra S; DeFilipp Z; Dholaria B; Perez MAD; Farhan S; Freytes CO; Gale RP; Ganguly S; Gupta V; Grunwald MR; Hamad N; Hildebrandt GC; Inamoto Y; Jain T; Jamy O; Juckett M; Kalaycio M; Krem MM; Lazarus HM; Litzow M; Munker R; Murthy HS; Nathan S; Nishihori T; Ortí G; Patel SS; van der Poel M; Rizzieri DA; Savani BN; Seo S; Solh M; Verdonck LF; Wirk B; Yared JA; Nakamura R; Oran B; Scott B; Saber W, 2023, 'Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis', Haematologica, 108, pp. 1900 - 1908, http://dx.doi.org/10.3324/haematol.2022.281958

Rees SJ; Hamad N, 2023, 'The need to accelerate COVID-19 education across medical schools', International journal of medical education, 14, pp. 75 - 76, http://dx.doi.org/10.5116/ijme.6488.1a6e

Saccardi R; Putter H; Eikema DJ; Busto MP; McGrath E; Middelkoop B; Adams G; Atlija M; Ayuk FA; Baldomero H; Beguin Y; de la Cámara R; Cedillo Á; Balari AMS; Chabannon C; Corbacioglu S; Dolstra H; Duarte RF; Dulery R; Greco R; Gusi A; Hamad N; Kenyon M; Kröger N; Labopin M; Lee J; Ljungman P; Manson L; Mensil F; Milpied N; Mohty M; Oldani E; Orchard K; Passweg J; Pearce R; de Latour RP; Poirel HA; Rintala T; Rizzo JD; Ruggeri A; Sanchez-Martinez C; Sanchez-Guijo F; Sánchez-Ortega I; Trnková M; Ferreiras DV; Wilcox L; de Wreede LC; Snowden JA, 2023, 'Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, 58, pp. 659 - 666, http://dx.doi.org/10.1038/s41409-023-01924-6

Mills GS; Chadwick V; Tang C; Perram J; Anderson MA; Anazodo A; Kidson-Gerber G; Shand A; Lavee O; Withers B; Milliken S; Di Ciaccio PR; Hamad N, 2023, 'Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility', The Lancet Haematology, 10, pp. e458 - e467, http://dx.doi.org/10.1016/S2352-3026(23)00059-5

Coutsouvelis J; Kirkpatrick CM; Dooley M; Spencer A; Kennedy G; Chau M; Huang G; Doocey R; Copeland TS; Do L; Bardy P; Kerridge I; Cole T; Fraser C; Perera T; Larsen SR; Mason K; O'Brien TA; Shaw PJ; Teague L; Butler A; Watson AM; Ramachandran S; Marsh J; Khan Z; Hamad N, 2023, 'Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study', Transplantation and Cellular Therapy, 29, pp. 383.e1 - 383.e10, http://dx.doi.org/10.1016/j.jtct.2023.03.014

Lim KJC; Di Ciaccio P; Polizzotto MN; Milliken S; Cochrane T; Goh Z; Shaw B; Perry E; Gilbertson M; Kermode W; Cheah CY; Latimer M; Hamad N; Ku M, 2023, 'Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance', British Journal of Haematology, 201, pp. 865 - 873, http://dx.doi.org/10.1111/bjh.18704

Di Ciaccio PR; Mills G; Shipton MJ; Campbell B; Gregory G; Langfield J; Greenwood M; McKeague S; Shanavas M; Eslick R; Kidson-Gerber G; Smallbone P; Tang C; Morris K; Bilmon I; Yannakou CK; Badoux X; Berkahn L; Farina S; Mason KD; Motum P; Goss K; Hamad N, 2023, 'The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance', British Journal of Haematology, 201, pp. 887 - 896, http://dx.doi.org/10.1111/bjh.18727

Goh Z; Latimer M; Lewis KL; Cheah CY; Ciaccio PD; Cushion T; Hawkes EA; Harrop S; Ku M; Campbell A; Hamad N; Wood EM; Chung E; Chen PY; Cochrane T, 2023, 'Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study', Clinical Lymphoma, Myeloma and Leukemia, 23, pp. 370 - 378, http://dx.doi.org/10.1016/j.clml.2023.01.014

Tokaz MC; Baldomero H; Cowan AJ; Saber W; Greinix H; Koh MBC; Kröger N; Mohty M; Galeano S; Okamoto S; Chaudhri N; Karduss AJ; Ciceri F; Colturato VAR; Corbacioglu S; Elhaddad A; Force LM; Frutos C; León AGD; Hamad N; Hamerschlak N; He N; Ho A; Huang XJ; Jacobs B; Kim HJ; Iida M; Lehmann L; de Latour RP; Percival MEM; Perdomo M; Rasheed W; Schultz KR; Seber A; Ko BS; Simione AJ; Srivastava A; Szer J; Wood WA; Kodera Y; Nagler A; Snowden JA; Weisdorf D; Passweg J; Pasquini MC; Sureda A; Atsuta Y; Aljurf M; Niederwieser D, 2023, 'An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia', Transplantation and Cellular Therapy, 29, pp. 279.e1 - 279.e10, http://dx.doi.org/10.1016/j.jtct.2022.12.013

Nguyen J; Wellard C; Chung E; Cheah CY; Dickinson M; Doo NW; Keane C; Talaulikar D; Berkahn L; Morgan S; Hamad N; Cochrane T; Johnston AM; Forsyth C; Opat S; Barraclough A; Mutsando H; Ratnasingam S; Giri P; Wood EM; McQuilten ZK; Hawkes EA, 2023, 'Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry', European Journal of Haematology, 110, pp. 386 - 395, http://dx.doi.org/10.1111/ejh.13915

Noyola-Pérez A; Gil-Flores L; Martínez-Espinosa HA; Ramos-Barrera E; Rodríguez-González V; Sung L; Guzman M; Hamad N; Colunga-Pedraza PR; Tarín-Arzaga L; Cantú-Rodríguez OG; Gutiérrez-Aguirre H; Jaime-Pérez JC; Gómez-Almaguer D; León AGD, 2023, 'Global representation among journal editors in haematology: are we diverse, equitable, and inclusive?', The Lancet Haematology, 10, pp. e246 - e247, http://dx.doi.org/10.1016/S2352-3026(23)00069-8

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255

Back to profile page